Senior investor and operating executive focused on growth-stage technology and healthcare companies, with expertise in go-to-market strategy, corporate development and board-level governance.
Sarah H. Schmidt brings extensive experience leading cross-functional teams at venture-backed startups and in corporate M&A, advising founders on scaling revenue and capital strategies. Known for sector-driven deal sourcing, portfolio value creation and hands-on operational support to management teams.
Senior investor and operating executive focused on growth-stage technology and healthcare companies, with expertise in go-to-market strategy, corporate development and board-level governance.
Sarah H. Schmidt brings extensive experience leading cross-functional teams at venture-backed startups and in corporate M&A, advising founders on scaling revenue and capital strategies. Known for sector-driven deal sourcing, portfolio value creation and hands-on operational support to management teams.
Growth-oriented investor leveraging operating leadership to back revenue-stage technology and healthcare companies, prioritizing deal flow from sector networks and founder-led teams. Focuses on pragmatic go-to-market and corporate development plays, allocating capital to scalable revenue models with clear path to enterprise adoption. Balances active board-level governance and hands-on operational support with measured capital pacing, emphasizing unit economics, customer retention, and exit optionality over headline valuations.
Growth-oriented investor leveraging operating leadership to back revenue-stage technology and healthcare companies, prioritizing deal flow from sector networks and founder-led teams. Focuses on pragmatic go-to-market and corporate development plays, allocating capital to scalable revenue models with clear path to enterprise adoption. Balances active board-level governance and hands-on operational support with measured capital pacing, emphasizing unit economics, customer retention, and exit optionality over headline valuations.
| Trades 1446 | Longs Won 910/1446 62% | Profit Factor 6.43 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $767,216.2 |
| Average Win $202,366.05 | Best Trade (Oct 16) $18.24M | Sharpe Ratio -9.53 |
| Average Loss -$53,451.84 | Worst Trade (Dec 30) -$4.65M | Z-Score 5.35 (100%) |
| Commissions $0 | Avg. Trade Length 5m 2w 1d | Expectancy $107,540.05 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 22,727 | 20,455 | 18,182 | 15,909 | 13,636 | 11,364 | 9,091 | 6,818 | 4,545 | 2,273 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 1,651 | $219,302 | $286,729.17 | - | $67,427.17 | 30.75% | -1.071% |
AAPL Apple Inc. | 97,815 | $22.47M | $33.69M | - | $11.22M | 49.93% | +0.711% |
ABBV AbbVie Inc. | 3,165 | $717,773.99 | $902,800.42 | - | $185,026.43 | 25.78% | +0.651% |
ABT Abbott Laboratories | 2,453 | $293,939.83 | $257,147.99 | - | -$36,791.84 | -12.52% | +0.143% |
ACYN FT Vest Laddered Autocallable Barrier & Income ETF | 21,465 | $446,257 | $444,540.15 | - | -$1,716.85 | -0.38% | -0.241% |
ACYS FT Vest Laddered Autocallable Barrier & Resilient Income ETF | 19,198 | $394,327 | $392,983.06 | - | -$1,343.94 | -0.34% | +0.049% |
ADI Analog Devices, Inc. | 746 | $296,360 | $301,936.04 | - | $5,576.04 | 1.88% | +0.196% |
AFL Aflac Inc. | 21,928 | $2.41M | $2.61M | - | $192,510.78 | 7.98% | +0.652% |
AGG iShares Core U.S. Aggregate Bond ETF | 15,420 | $1.54M | $1.47M | - | -$67,294.7 | -4.38% | -0.157% |
AHR American Healthcare REIT, Inc. | 28,126 | $1.33M | $1.49M | - | $159,008.18 | 11.93% | +0.038% |
AIRR First Trust RBA American Industrial Renaissance ETF | 7,196 | $763,865.78 | $715,246.42 | - | -$48,619.36 | -6.36% | -1.011% |
ALGN Align Technology, Inc. | 1,639 | $219,349.68 | $243,014.53 | - | $23,664.85 | 10.79% | -0.716% |
ALL Allstate Corporation | 1,552 | $323,859.84 | $376,569.52 | - | $52,709.68 | 16.28% | +1.267% |
AMAT Applied Materials, Inc. | 2,839 | $740,433.56 | $1.19M | - | $445,842.59 | 60.21% | -2.828% |
AMD Advanced Micro Devices, Inc. | 2,360 | $576,185.61 | $1.28M | - | $700,999.19 | 121.66% | -3.744% |
AMGN Amgen Inc. | 2,129 | $652,135.82 | $925,859.52 | - | $273,723.7 | 41.97% | +0.196% |
AMZN Amazon.com Inc | 37,083 | $7.99M | $9.31M | - | $1.32M | 16.5% | -1.433% |
ANET Arista Networks, Inc. | 1,660 | $203,815.1 | $297,671.2 | - | $93,856.1 | 46.05% | -3.373% |
APH Amphenol Corporation | 7,156 | $226,043.73 | $574,519.46 | - | $348,475.73 | 154.16% | -1.479% |
APP AppLovin Corporation Class A Common Stock | 581 | $231,238 | $156,474.92 | - | -$74,763.08 | -32.33% | -3.57% |